Found "Public health policy": 1,134 results
Sort by
Relevance

Chayapat Rachatan

Chayapat Rachatan is currently a Project Associate at HITAP. She supports the HTA and health system research. Her research studies focus on COVID-19 policy research and decision support, effectiveness evaluation of COVID-19 vaccine chatbot, cost analysis of governance system in health sector, situational analysis of infectious disease modelling in

Trends and predictors of caesarean section in Thailand before and during the COVID-19 pandemic: a retrospective analysis of national hospitalisation data under the Universal Coverage Scheme

Abstract   Objectives: Since 1985, the international healthcare community has recommended the ideal rate of caesarean section (CS) to be 10%–15% at the national level. The literature has reported that overused CS without necessary medical indications can be harmful to both maternal and chil

A Study on Monitoring and Evaluating the Process of Universal Coverage Benefit Package and National List of Essential Medicines

67196067RU034L6benefits package,Universal health coverage (UHC),National List of Essential Medicines (NLEM),Monitoring and evaluation,Policy development,Health system

Evaluation of the National Essential Drug List Category E2 2008 (in Thai language)

The objective of this study is to promote the rational drug use of Thailand. E List, clause 2 for specific patients is added in the National List of Essential Medicines, 2551 B.E. Ten medicines, which require knowledge, specialization in disease or advanced technology, are included in the list. However, it is likely that the prescription of these m

Identifying information regarding effectiveness and cost-effectiveness of policy and strategies to mitigate the impact of HIV/AIDS in Thailand

This study aims to make a comprehensive list of HIV/AIDs preventative interventions that are likely to be effective and cost-effective. The review of Thai literature included both published and unpublished (grey) literature, which are considered to be important in the Thai context. If local data regarding the effectiveness or cost-effectiveness of

The 2nd evaluation of the technology and policy assessment program for health resource allocation (2009-2011)

Following an assessment1 of the core strategies of HITAP carried out by a team of Thai and UK investigators in 2007-2008, at the request of the Thai Health Promotion Foundation, HITAP has initiated a second evaluation, in 2011, this time bringing together a team of UK, Thai and Korean assessors. These recommendations were the result of data analysi

Evaluation of piloted Down’s Syndrome system

This research project assesses the implementation of a pilot project of screening of Down’s syndrome in primary healthcare facilities in five provinces including Chiang Mai, Lamphun, Nakhon Sawan, Khon Kaen, and Songkhla. Findings from the assessment will be used to improve the service delivery as well as to explore possibilities of scaling up th

Mathematical and economic modelling for optimal strategies to screen and treat chronic hepatitis C virus patients using novel antiviral agents with cost-effectiveness and budget impact analyses in Thai setting

Chronic hepatitis C virus (HCV) infection is a major cause of cirrhosis, end-stage liver disease and hepatocellular carcinoma (HCC). It has been calculated that 130-170 million people are infected with HCV, with a global prevalence of infection estimated at 2%-3%. Approximately 75%-85% of people infected with HCV will develop chronic hepatitis, 60%

Health Technology Assessment Development in Philippines

Since 2013, HITAP has supported HTA development and capacity building in the Philippines. In 2019, the Philippines mandated the provision of universal health coverage to all Filipinos. To support the decision-making for this promising undertaking, the partners continue their collaboration through technical assisatance on national HTA guidelines, on
10 / Page